Status:
COMPLETED
Dual MRI for Cardiopulmonary COVID-19 Long Haulers
Lead Sponsor:
Bastiaan Driehuys
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The next phase of the COVID-19 pandemic is likely to see a surge in an associated chronic cardiopulmonary disease that will challenge health systems. Recovered patients are presenting with persistent ...
Detailed Description
The proposed research builds on the established sensitivity of Hyperpolarized 129Xe MRI to obstructive and pulmonary vascular lung disease, features expected to represented in the Covid-19 cohort. It ...
Eligibility Criteria
Inclusion
- Diagnosis of post Coronavirus (COVID-19)
- Age ≥ 18-year-old
- Tested positive for SARS-CoV2
- Willing and able to give informed consent and adhere to visit/protocol scheduled (consent must be given before any study procedures are performed)
Exclusion
- Prisoners
- Pregnant, planning pregnancy, or lactating
- Conditions that prohibit MRI scanning (metal in eye, claustrophobia, inability to lie supine).
- Medical or psychological conditions which, in the opinion of the investigator, might create undue risk to the subject or interfere with the subject's ability to comply with the protocol requirements
Key Trial Info
Start Date :
May 26 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 20 2023
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT04828135
Start Date
May 26 2021
End Date
April 20 2023
Last Update
May 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke Asthma, Allergy, and Airway Center
Durham, North Carolina, United States, 27705